Related Experiment Video

Updated: Jun 23, 2026

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

Reassessing the impact of donor HLA-C genotype on long-term liver transplant survival

T H Tran1, D Middleton, B Döhler

  • 1Department of Transplantation Immunology, Institute of Immunology, University of Heidelberg, Heidelberg, Germany.

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
|April 28, 2009
PubMed

Insights

Donor HLA-C2 genotype does not impact long-term liver transplant survival. This study could not confirm previous findings suggesting a benefit of donor HLA-C2 alleles on graft and patient survival after liver transplantation.

Area of Science:

  • Immunogenetics
  • Transplantation immunology
  • NK cell biology

Background:

  • Human Leukocyte Antigen-C (HLA-C) is a key inhibitory ligand for killer immunoglobulin-like receptors (KIRs) on natural killer (NK) cells.
  • HLA-C alleles are classified into HLA-C1 and HLA-C2 groups based on KIR specificity.
  • Previous research suggested donor HLA-C group 2 alleles improve liver transplant outcomes by inhibiting host NK cell function.

Purpose of the Study:

  • To verify the association between donor HLA-C2 genotype and long-term graft and patient survival after liver transplantation.
  • To investigate the role of donor HLA-C2 genotype in liver allograft survival.

Main Methods:

  • Genotyping of 913 deceased liver donors for HLA-C KIR epitopes.
  • Correlation of donor HLA-C2 genotype presence or absence with 10-year graft and patient survival.

Main Results:

  • Donor HLA-C2 genotype showed no impact on 10-year graft survival.
  • Donor HLA-C2 genotype did not affect 10-year patient survival.
  • The study failed to confirm a significant role for donor HLA-C2 genotype in long-term liver allograft survival.

Conclusions:

  • The findings do not support a major role of donor HLA-C2 genotype in determining long-term allograft survival after liver transplantation.
  • The impact of donor HLA-C2 on liver transplant outcomes requires further investigation.
  • This study highlights the complexity of immunogenetic factors influencing transplant success.

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...